gins. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism. J. Neurophysiol. 82: 1768Neurophysiol. 82: -1775Neurophysiol. 82: , 1999. Most electrophysiological studies of opioids on hippocampal principal neurons have found indirect actions, usually through interneurons. However, our laboratory recently found reciprocal alteration of the voltage-dependent K ϩ current, known as the M-current (I M ), by and ␦ opioid agonists in CA3 pyramidal neurons. Recent ultrastructural studies have revealed postsynaptic ␦ opiate receptors on dendrites and cell bodies of CA1 and CA3 hippocampal pyramidal neurons (HPNs). Reasoning that previous electrophysiological studies may have overlooked voltage-dependent postsynaptic effects of the opioids in CA1, we reevaluated their role in CA1 HPNs using the rat hippocampal slice preparation for intracellular currentand voltage-clamp recording. None of the ␦ and receptor-selective opioids tested, including {D-Pen 2,5 }-enkephalin (DPDPE), {D-Ala 2 }deltorphin II (deltorphin), {D-Ala 2 , NMe-Phe 4 , Gly-ol}-enkephalin (DAMGO), and {D-Ala 2 , D-Leu 5 } enkephalin (DADLE), altered membrane properties such as I M or Ca 2ϩ -dependent spikes in CA1 HPNs. The nonopioid, Des-Tyr-dynorphin (D-T-dyn), also had no effect. By contrast, dynorphin A (1-17) markedly increased I M at low concentrations and caused an outward current at depolarized membrane potentials. The opioid antagonist naloxone and the receptor antagonist nor-binaltorphimine (nBNI) blocked the I M effect. However, the -selective agonists U69,593 and U50,488h did not significantly alter I M amplitudes when averaged over all cells tested, although occasional cells showed an I M increase with U50,488h. Our results suggest that dynorphin A postsynaptically modulates the excitability of CA1 HPNs through opiate receptors linked to voltagedependent K ϩ channels. These findings also provide pharmacological evidence for a functional opiate receptor subtype in rat CA1 HPNs but leave unanswered questions on the role of ␦ receptors in CA1 HPNs.
I N T R O D U C T I O N
Although the rodent hippocampus contains opioid peptides and opiate receptors, the functional role of these elements is still under investigation. Nonetheless, after two decades of research, several concepts have emerged (see ); these include 1) the reported lack of direct effect of the opioids on pyramidal neurons (Nicoll et al. 1980; Siggins 1990; Siggins and Zieglgänsberger 1981; Zieglgänsberger et al. 1979) , 2) the well-known disinhibitory effect of ␦ and opioids mediated by inhibitory opiate receptors on interneurons (Lupica and Dunwiddie 1991; Madison et al. 1987; Zieglgänsberger et al. 1979) , and 3) the presence of presynaptic opiate receptors that inhibit transmitter release (Castillo et al. 1996; Salin et al. 1995; Wagner et al. 1992; Weisskopf et al. 1993) and may be involved in depressing some forms of long-term potentiation (LTP) (Wagner et al. 1993; Weisskopf et al. 1993 ). However, subsequent intracellular studies in our laboratory (Moore et al. 1994) showed that opioids could act directly on rat CA3 hippocampal pyramidal neurons (HPNs): agonists selective for opiate receptors enhanced the voltagedependent I M , whereas ␦ (but not ) agonists reduced I M . In contrast, Salin et al. (1995) reported that CA3 HPNs in several species did not show such direct postsynaptic effects of opioids.
Autoradiographic studies have revealed receptor binding in the rat hippocampal pyramidal cell layer (Tempel and Zukin 1987; Zukin et al. 1988 ). In an immunohistochemical study, Arvidsson et al. (1995b) showed that receptors are located on both post-and presynaptic elements in rat and guinea pig. In contrast, Drake et al. (1996) reported that receptors are located presynaptically in the guinea pig hippocampal formation. Electrophysiological studies have suggested that dynorphin may activate but not receptors in CA1 neurons (Chavkin et al. 1985a; Neumaier et al. 1988) . Similarly, results of previous electrophysiological and binding studies suggested that opiate receptors (mostly and ␦) were located primarily on elements presynaptic to CA1 and CA3 HPNs (Unnerstall et al. 1983; Zieglgänsberger et al. 1979 ). However, the recent ultrastructural studies of Commons and Milner (1997) , using antisera raised against the cloned ␦ opiate receptor, have revealed postsynaptic ␦ opiate receptors on dendrites and cell bodies of CA1 and CA3 HPNs. Thus these anatomic findings seemed to corroborate our previous positive findings in CA3 HPNs that ␦ agonists postsynaptically reduced the I M K ϩ conductance (Moore et al. 1994) . Therefore, reasoning that previous studies may have overlooked voltage-dependent postsynaptic effects of the opioids in CA1 HPNs, we have now reevaluated the action of various opioids on these principal neurons. We found that CA1 HPNs showed no response to application of several ␦and -selective agonists, yet low concentrations of dynorphin A more selective for receptors augmented the voltage-sensitive I M .
M E T H O D S

Slice preparation
We used standard intracellular current-and voltage-clamp recording techniques in the rat hippocampal slice, prepared as described previously (Madamba et al. 1996) . In brief, male Sprague-Dawley rats (100 -170 g) were anesthetized with 3% halothane, decapitated, and
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. their brains rapidly removed and placed in ice-cold artificial cerebral spinal fluid (ACSF) gassed with 95% O 2 -5% CO 2 . We cut transverse hippocampal slices 350 m thick on a McIlwain-type brain slicer, incubated them in an interface configuration for ϳ30 min, and then completely submerged and continuously superfused the slices with gassed ACSF of the following composition (in mM): 130 NaCl, 3.5 KCl, 1.25 NaH 2 PO 4 , 1.5 MgSO 4 ⅐7H 2 O, 2.0 CaCl 2 , 24 NaHCO 3 , and 10 glucose. Other ions and drugs were added to the ACSF in known concentrations. Slices were superfused with warm (31°C), gassed ACSF, at a continuous, constant flow rate of 2-4 ml/min. We used sharp glass micropipettes filled with 3 M KCl (tip resistance, 67 Ϯ 2 M⍀; mean Ϯ SE) to penetrate HPNs. Methods of superfusion, voltage-clamp recording, cell identification, drug administration, and data analysis were as described previously (Madamba et al. 1996; Moore et al. 1994; Schweitzer et al. 1993 ).
Electrophysiological methods
Current and voltage were recorded with an Axoclamp-2A preamplifier (Axon Instruments) and filtered at 0.3 kHz. Continuous current and voltage records were stored on polygraph paper. We digitized data by D/A sampling and acquisition software (pClamp; Axon Instruments) and stored them on computer disk for data analysis via Clampfit software (Axon Instruments). Tetrodotoxin (TTX; 1 M) was added to block Na ϩ -dependent action potentials and inhibit synaptic transmission. In discontinuous single-electrode voltage-clamp mode, the switching frequency was 3-4 kHz; we continuously monitored electrode settling time and input capacitance neutralization at the headstage on a separate oscilloscope (Finkel and Redman 1985) . Current-voltage (I-V) relationships were generated from a holding potential of Ϫ60 Ϯ 0.3 mV with hyperpolarizing and depolarizing steps of 1.5 s duration. Problems (e.g., space clamping) associated with voltage clamp in neurons with extended processes are discussed elsewhere (Finkel and Redman 1985; Halliwell and Adams 1982; Johnston and Brown 1983) . These problems are less acute when studying relative changes following drug application (see Madison et al. 1987) , especially in the presence of agents such as TTX and Cd 2ϩ that block large Na ϩ and Ca 2ϩ conductances.
M-current analysis
In CA1 HPNs, I M is seen with holding potentials around Ϫ45 mV and hyperpolarizing steps of 5-25 mV and 700 -1,000 ms durations (Halliwell and Adams 1982; Moore et al. 1994) ; under these conditions it appears as a slow inward "relaxation" following the instantaneous (ohmic) inward current drop (see Fig. 1 ). We measured I M amplitude with software (Clampfit, Axon Instruments) that fitted two exponential curves to the I M relaxation and used the difference between the instantaneous peak current at command onset and the steady-state current just before command offset to quantify the amplitude of I M (Fig. 1 ). Tail (off-command) currents were not analyzed because of possible contamination with other currents (e.g., I A or I T ). Usually, an initial current (capacitative) artifact of 5-20 ms duration was present at command onset (Halliwell and Adams 1982) . Therefore we fitted the current relaxation via Clampfit (Chebyshev method) to the peak of the initial current that usually fell within 5-20 ms of step onset after complete settling of the capacity transient (see Fig. 1 ).
Drug administration
Drugs and peptides were made from a stock solution and added to the ACSF in known concentrations immediately before administration to the slice chamber. The usual drug protocol followed for agonist testing was to record currents during superfusion of ACSF alone ("control"), followed by switching to ACSF with drug and repeating these current measures after 4 -10 min of drug superfusion, followed by switching again to ACSF alone for 10 -30 min with subsequent current measures ("washout"). The cell was depolarized to Ϫ40 to Ϫ49 mV for I M analysis at each of the three periods but was held near resting membrane potential (RMP) between these periods to avoid the instabilities that might develop with prolonged depolarization (see Halliwell and Adams 1982) . For tests of the opioid antagonists, the usual protocol involved first applying the opioid agonist, followed by washout with ACSF alone, followed by adding the antagonist to the superfusate (to test possible effects on baseline properties), followed by addition of the opioid agonist together with the antagonist. At the end of some recordings, we added 30 M carbachol (CCh) or 2 mM Ba 2ϩ to the superfusate to verify I M relaxation.
We obtained dynorphin A, DAMGO, DPDPE, deltorphin, D-T-dyn, and DADLE from Peninsula Laboratories (Belmont, CA). U69,593, U50,488h, and nBNI were obtained from Research Biochemicals International (Natick, MA). We obtained naloxone from Sigma (St. Louis, MO) and TTX from Calbiochem-Novabiochem (San Diego, CA).
Quantification and statistics
All measures are reported as means Ϯ SE. I-V relationships were plotted by Origin 4.0 software (Microcal Software) using B-spline lines. We determined statistical significance by two-way ANOVA for repeated measures and the Newman-Keuls post hoc test when appropriate.
R E S U L T S
We recorded from a total of 57 CA1 HPNs. These neurons had an average RMP of Ϫ69 Ϯ 0.3 mV (n ϭ 51) and average spike amplitude of 105 Ϯ 1 mV (n ϭ 44). Stable recordings could be maintained for up to 4 h, suggesting a relative lack of injury by the electrode penetration. We studied I M using voltage clamp at a mean holding potential of Ϫ43 Ϯ 0.2 mV. Several lines of evidence suggest, as reported previously (Halliwell and Adams 1982; Moore et al. 1994 ), that the current relaxations we recorded represented I M : 1) the relaxations were suppressed by the muscarinic agonist carbachol (30 M) or by 2 mM Ba 2ϩ , and 2) the magnitude, kinetics, and voltage dependence of the relaxations were equivalent to those of I M previously reported (Halliwell and Adams 1982; Moore et al. 1988a; Schweitzer et al. 1993) .
We tested seven different opioid agonists: 1) DPDPE, a ␦ 1 -selective opioid peptide; 2) deltorphin, a ␦ 2 -selective opioid; 3) DAMGO, a -selective opioid; 4) DADLE, a broadly ef-FIG. 1. Protocol for exponential fitting of I M relaxations (modified from Schweitzer et al. 1993 ). The I M relaxation is fitted (dotted line superimposed on current trace) using Clampfit software (Axon Instruments). For illustration purposes only, the dotted line is extrapolated beyond the peak and steady-state of the current trace. The I M relaxation amplitude was calculated as the difference between the instantaneous peak and steady-state current values (see METHODS). fective opioid peptide capable of activating several receptor subtypes but especially and ␦; 5) dynorphin A (1-17), an opioid relatively selective for receptors at low concentrations but less selective at higher concentrations; 6) U50,488h, and 7) U69,593, opioids selective for the opiate receptor subtype. We also tested D-T-dyn to rule out possible nonopioid effects. For any given CA1 neuron, the effects measured were usually opioid-induced currents at rest, changes in I M amplitudes, and changes in I-V relationships. For the ␦ agonists, we also examined Ca 2ϩ -dependent spikes.
Resting and steady-state currents
On average, superfusion of DPDPE, deltorphin, DAMGO, or DADLE (1-8 M concentrations) induced little current measured near RMP and had no effect on I-V curves (Table 1 ; Fig. 2C ). At more depolarized membrane potentials (near Ϫ45 mV), these opioid peptides only induced small, statistically insignificant inward currents (mean Ϫ32 Ϯ 49, Ϫ15 Ϯ 22, and Ϫ18 Ϯ 57 pA, respectively; DADLE effects were not determined; see Fig. 3 and Table 1 ). In contrast, 0.5 M dynorphin had a marked effect near Ϫ45 mV: it induced a mean outward current of 178 Ϯ 13 pA, but only 3 Ϯ 11 pA near RMP. Similarly 1 M dynorphin induced 214 pA near Ϫ45 mV and only 12 pA near RMP (Table 1 ). Figure 4A shows the effect of dynorphin on the steady-state current values of a CA1 neuron held at Ϫ59 mV and subjected to hyperpolarizing and depolarizing voltage steps. Superfusion of 0.5 M dynorphin induced an outward current at depolarized membrane potentials that reversed around Ϫ90 mV ( Fig. 4A ) but induced little current near RMP (Ϫ69 mV for this cell). A lower concentration of dynorphin (0.1 M) had little effect (4 pA) near Ϫ45 mV in two cells. Although on average 4 -8 M U50,488h had no significant effect on mean I M amplitudes (see M-currents), it evoked a mean outward current of 98 Ϯ 22 pA near Ϫ45 mV in three cells. In contrast, 1 M U69,593 induced little current across the voltage range tested. Similarly, 1 M D-T-dyn had no effect on steady state currents (Table 1) .
Ca 2ϩdependent spikes
Because of the relative lack of effect of ␦ agonists on resting currents, and because of the clear presence of ␦ receptors on CA1 HPNs (Commons and Milner 1997) , we also explored a possible effect of ␦ agonists on Ca 2ϩ -dependent spikes. Because of difficulties in adequately recording Ca 2ϩ currents in slice preparations, these experiments were performed in current-clamp mode in the presence of 1 M TTX to block Na ϩ -dependent spikes. Superfusion of the selective ␦ 1 -receptor agonist DPDPE (1 M) had little effect on the Cd 2ϩ -sensitive Ca 2ϩ -dependent spikes elicited by depolarizing voltage steps ( Fig. 2A; n ϭ 2) . Similarly, the selective ␦ 2 receptor agonist deltorphin (1 M) also had little effect on Ca 2ϩ -dependent spikes, RMP, or slope resistance in CA1 HPNs (Fig. 2, B and C; n ϭ 2).
M-currents
None of theor ␦-selective opiate agonists altered I M relaxation amplitudes in CA1 neurons (Fig. 3) . Thus, averaging data from seven neurons, superfusion of 1-5 M DPDPE did not significantly (P Ͼ 0.1) alter I M amplitudes when compared (3) Values are means Ϯ SE in pA; numbers in parentheses refer to number of cells measured near Ϫ45 mV or near resting membrane potential (RMP). Positive numbers represent outward (hyperpolarizing) current, and negative numbers represent inward (depolarizing) current. HPNs, hippocampal pyramidal neurons; ND, not determined. (100 M) superfusion for 7 min almost totally blocked the spikes, suggesting that they were Ca 2ϩ -dependent. Resting membrane potential (RMP) was Ϫ68 mV. B: superfusion of 1 M deltorphin for 10 min onto another neuron had no effect on the Ca 2ϩ -dependent spikes evoked in the presence of 1 M TTX. RMP was Ϫ68 mV (arrow). C: V-I relationships of the steady-state potentials from the neuron shown in B.
with control values (Fig. 3C, left panel) . Likewise, the selective ␦ 2 -receptor agonist deltorphin (1 M) did not significantly change I M amplitudes in five cells (Fig. 3, B and C, middle panel; P Ͼ 0.9). The -selective agonist DAMGO (1-2 M; n ϭ 5) also did not significantly (P Ͼ 0.5) change I M amplitudes ( Fig. 3C, right panel) . In two cells, 4 -8 M DADLE also had little effect on I M amplitudes (data not shown).
Interestingly, in the same cells where 1 M deltorphin had no effect on I M amplitude, subsequent superfusion of 0.5 M dynorphin clearly augmented I M (data not shown). Dynorphin A (0.5 M) markedly induced an outward holding current concomitant with an increased I M amplitude, with recovery on washout (Fig.  4B ). In the same cell after 23 min washout of the first exposure, a second application of 0.5 M dynorphin again increased I M amplitudes, suggesting a lack of tachyphylaxis over this period. In data pooled from eight cells, superfusion of 0.5 M dynorphin significantly [F(2,14) ϭ 79.11, P Ͻ 0.001; Newman-Keuls, P Ͻ 0.01; for all conditions] increased mean I M relaxation amplitudes to 160% of control with recovery on washout (Fig. 5B1) . Similarly, in three cells 1 M dynorphin increased I M amplitudes to 169% of control (averaged values taken from 10 to 20 mV hyperpolarizing steps). In contrast, a lower concentration of dynorphin (0.1 M) had no effect on I M (n ϭ 2; data not shown). Thus the maximally effective concentration for dynorphin was 0.5 M, and the apparent EC 50 for this relatively steep dose-response relationship must fall between 0.1 and 0.5 M. Figure 5A shows a representative recording: superfusion of 0.5 M dynorphin A enhanced I M amplitudes, elicited a steady-state outward current (cf. dashed line) and increased input conductance in a CA1 HPN; this response was prevented by the selective antagonist nBNI (1 M). Subsequent superfusion of 30 M carbachol (CCh; n ϭ 4) elicited an inward steady-state current and totally blocked the inward current relaxations, verifying the identity of the relaxations as due to I M . On average, 1 M nBNI (n ϭ 3) or 4 M naloxone (n ϭ 1) totally prevented the augmenting effect of 0.5 M dynorphin on I M (Fig. 5B2) .
The blockade by nBNI of the dynorphin-induced I M augmentation indicated that this effect was mediated by receptors. We therefore tested the selective agonist U50,488h. Superfusion of 4 M U50,488h clearly can increase I M amplitude in some individual CA1 HPNs (Fig. 6, A and B) , with recovery on washout. In addition, in the same cell a 0.5 M dynorphin-induced I M increase was blocked by 4 M naloxone. However, when averaged across all six cells studied, superfusion of 4 -8 M U50,488h only slightly increased I M amplitudes. This effect did not reach statistical significance (n ϭ 6; P Ͼ 0.1; Fig. 6C ). Similarly, in five cells 1 M U69,593 had no significant (P Ͼ 0.5) effect on I M amplitude.
D I S C U S S I O N
In this study we found that, in the presence of TTX, superfusion of opiates selective for ␦ 1 , ␦ 2 and receptors did not alter I M or other postsynaptic properties in rat CA1 HPNs. By contrast, dynorphin A significantly enhanced I M amplitudes, and this effect was blocked by naloxone and the selective receptor antagonist, nBNI. However, U69,593 and U50,488h did not significantly alter I M amplitudes, although some individual cells showed a clear I M augmentation with U50,488h. Both U50,488h and dynorphin A induced an outward steady-state current near Ϫ45 mV where I M persists. These findings suggest that a pharmaco- logically functional receptor subtype exists in rat CA1 neurons and that opiates may have more complex actions than the simple disinhibitory or presynaptic effects that have received the most attention in hippocampus.
Absence of voltage-dependent effects of ␦ and agonists on HPNs
The selective ␦ 1 and ␦ 2 receptor agonists (DPDPE and deltorphin) did not alter Ca 2ϩ -dependent spikes in CA1 HPNs, suggesting a lack of effect on voltage-dependent Ca 2ϩ currents. However, there is the caveat that such current-clamp studies offer a relatively insensitive index of drug effects on Ca 2ϩ currents, and that reciprocal opioid effects on the different subtypes of Ca 2ϩ currents could result in false-negative results. Unfortunately, voltageclamping Ca 2ϩ currents in CA1 slice neurons with extended processes is difficult due to space-clamp confounds combined with the positive step potentials needed (around 0 mV) and the typically large Ca 2ϩ current amplitudes. However, M-currents have smaller current amplitudes and are easier to record at more negative potentials (near Ϫ45 mV).
In voltage-clamp recordings, opioid peptides selective for ␦ 1 , ␦ 2 , and receptors had little effect on the voltage-dependent I M . On average, these peptides had no effect near RMP or near Ϫ45 mV (see Table 1 ). In view of the recent observation of ␦ receptors on CA1 HPNs (Commons and Milner 1997) and our finding of I M depression by ␦ agonists in CA3 (Moore et al. 1994) , the lack of postsynaptic effect of ␦ receptor agonists on I M in CA1 HPNs was unexpected. Similarly, the agonist DAMGO had no clear effect on I M or Ca 2ϩ spikes, despite the reported postsynaptic localization of receptors in CA1 neurons (Arvidsson et al. 1995b) . It may be argued that we have not examined several other voltage-sensitive currents, such as I A , I D , I T , and delayed rectifier currents. These are inactivating currents that may not influence resting properties. Modulatory effects of the opioids on other postsynaptic transmitter receptors, such as those for glutamate (see Deisz et al. 1988; Martin et al. 1997) , could also be a site of action. Thus postsynaptic ␦ receptors could play a role in phosphorylation and desensitization of receptors, leading to neuroadaptive processes as demonstrated for the receptor (Zhang et al. 1996) .
Nevertheless, our results indicating a lack of clear postsynaptic effect of ␦or -selective agonists in CA1 HPNs are in agreement with previous studies supporting the disinhibition hypotheses (Nicoll et al. 1980; Siggins and Zieglgänsberger 1981; Zieglgänsberger et al. 1979 ). These opiate receptor agonists have been shown to reduce GABAergic transmission in hippocampus (Lupica and Dunwiddie 1991; Lupica et al. 1992) , and an intracellular study of hippocampal interneurons showed that they were directly hyperpolarized by enkephalins (Madison and Nicoll 1988) .
Postsynaptic effects of dynorphin
In contrast to the lack of effects of and ␦ agonists on CA1 HPNs, we found that dynorphin A significantly enhanced I M amplitudes, with recovery on washout. Dynorphin A also induced F(2,14) ϭ 79.108, P Ͻ 0.001; Newman-Keuls P Ͻ 0.01 for all conditions] increase of up to 60% during 0.5 M dynorphin superfusion. B2: mean I M amplitudes during superfusion of 0.5 M dynorphin A (Dyn) in the presence of opiate receptor antagonists naloxone (4 M; n ϭ 1) or nBNI (1 M; n ϭ 3). Note the complete lack of effect of dynorphin in the presence of the antagonists. Error bars ϭ SE. an outward steady-state current in the depolarized range, probably a consequence of its effects on I M . Although dynorphin is an agonist at the receptor (Chavkin et al. 1982) , previous extracellular studies have suggested that higher concentrations of dynorphin A increased CA1 population spike amplitude by acting on presynaptic receptors (Chavkin et al. 1985a; Neumaier et al. 1988) to reduce release of an inhibitory neurotransmitter. However, in the present studies DAMGO did not affect CA1 HPNs, suggesting that the receptor subtype is not involved in dynorphin enhancement of I M . By contrast, the nBNI block of dynorphin A-induced augmentation of I M suggests the presence of a pharmacologically functional postsynaptic receptor in CA1 neurons. U50,488h slightly (but not significantly) enhanced I M amplitudes (see Fig. 6 ); this apparent negative effect might be due to receptor-subtype variation (see next paragraph). Similarly, U69,593 had little effect on I M amplitudes or on steady-state currents, further implying that a 1 receptor was not involved. This finding was unexpected because the dynophin A enhancement of I M amplitudes was blocked by nBNI, suggesting receptor mediation. In keeping with its slight enhancement of I M , U50,488h also induced a clear outward current (mean: 98 Ϯ 22 pA) near Ϫ45 mV but not near RMP (see Table 1 ). The dynorphin A enhancement of I M amplitude is not likely to be a nonspecific peptide effect because D-T-dyn had no effect on membrane properties in HPNs.
There are reports of dynorphin-like immunoreactive fibers located in the hippocampal CA1 region (Chavkin et al. 1985b; McGinty et al. 1983) , and several receptor subtypes (e.g., 1 , 2 , or epsilon) are located in the rat brain (Nock et al. 1988 (Nock et al. , 1990 (Nock et al. , 1993 Zukin et al. 1988) , where the 2 receptor subtype predominates. Dynorphin has a higher potency than U50,488h for the 2 subtype (Zukin et al. 1988) . The lower affinity of the 2 receptor for U50,488h may explain the lack of significant I M enhancement by U50,488h. Furthermore, U69,593 is specific for 1 receptor and is inactive at the 2 receptor, suggesting that a 1 receptor is not involved. However, our finding of nBNI blockade of dynophin enhancement of I M might suggest 1 receptor mediation. Although it has been suggested that nBNI is a selective 1 antagonist (Nock et al. 1990) , it may also interact with the 2 receptor subtype (see Wollemann et al. 1993 for review) . Previously, we reported that U50,488h significantly enhanced I M amplitudes in CA3 HPNs (Moore et al. 1994) , with nBNI blockade of this effect. It is possible that some new, uncharacterized receptor subtype or splice variant is responsible for the dynorphin effect on I M in CA1 HPNs (see Clark et al. 1989 ; and our accompanying paper Madamba et al. 1999) . Furthermore, the exact localization of receptors in the rat CA1 region is presently unknown.
Our finding of large I M increases induced by dynorphin in rat CA1 HPNs is highly consistent with the significant dynorphininduced I M increases we reported previously for rat CA3 HPNs (Moore et al. 1994) . In contrast to our CA3 findings of decreased I M by higher dynorphin concentrations (Ͼ0.5 M), CA1 neurons showed only augmentation of I M at all dynorphin concentrations tested above 0.1 M. However, Salin et al. (1995) found no postsynaptic dynorphin effects in CA3 HPNs of several species, including rat. The inability to replicate our I M data may arise from several differences in our experimental conditions, such as 1) possible contamination of the apparent I M relaxation with the Q-current relaxation that is not altered by opioids in CA3 neurons (Moore et al. 1994) ; 2) the method for quantifying the I M relaxations; 3) bath temperature; 4) dynorphin concentrations; and 5) the presence or absence of Ca 2ϩ channel antagonists.
Past publications (e.g., North et al. 1987; Piguet and North 1993; Williams and North 1984; Williams et al. 1988 ) on neuronal opiate effects had postulated that, in addition to the well-known presynaptic inhibitory effects of opiates on transmitter release, agonists specific for and ␦ receptors exerted their inhibitory effects by opening K ϩ channels, whereas those specific for receptors did not, but rather inhibited Ca 2ϩ channel function (Gross and MacDonald 1987) . However, several studies (Deisz et al. 1988; Martin et al. 1997; Moore et al. 1988b; Siggins and Zieglgänsberger 1981; Sutor and Zieglgänsberger 1984; Yuan et al. 1992) , including the present investigation, found that many central neurons showed no direct inhibitory effects of or ␦ agonists attributable to K ϩ channel activation. By contrast, the Moore et al. (1994) studies and those of others (Grudt and Williams 1993; Henry et al. 1995; Ikeda et al. 1995; Ma et al. 1995; Simmons and Chavkin 1996) , have shown that agonists clearly can activate K ϩ channels in several neuron types and in Xenopus oocytes coexpressing -opioid receptors and K ϩ channels. As the Mcurrent is carried through K ϩ channels, the present study, and the accompanying paper on nociceptin, adds further evidence that agonists open K ϩ channels. 
Physiological role of hippocampal dynorphin
As for the function of endogenous opioids in CA1 hippocampus, regulation of the M-current could play an important role in events that involve prolonged depolarizations, such as those triggered during theta burst activity. Dynorphin-or nociceptin-induced augmentation of I M would be predicted to counter prolonged depolarizations and reduce bursting activity (Halliwell and Adams 1982) . Considerable evidence suggests that opiates play some as yet undefined role in epileptiform activity. The epileptigenic action of agonists in CA1 and CA3 neurons may arise from inactivation of inhibitory interneurons in hippocampus (Nicoll et al. 1980; Siggins and Zieglgänsberger 1981; Zieglgänsberger et al. 1979) . By contrast, several reports suggest that dynorphins dampen epileptiform activity (Jones 1991; Tortella and Holaday 1986) , consistent with an inhibitory action via K ϩ channel/I M augmentation. Changes of dynorphin levels and metabolism in hippocampus following evoked seizure activity (Gall 1988; Hong et al. 1988 ) also may indicate a role for dynorphin in seizures.
Dynorphin also could be involved in some form of synaptic plasticity. Several studies have shown that dynorphin depresses LTP, a cellular model for learning and memory, in guinea pig hippocampus (Terman et al. 1994; Wagner et al. 1993; Weisskopf et al. 1993 ). However, the locus of this effect is thought to be presynaptic, in part because dynorphin was assumed to have no postsynaptic action. By contrast, ␦and/or -selective agonists enhanced LTP in rat hippocampus (Derrick et al. 1992; Gramham et al. 1991; Xie and Lewis 1995) . DAMGO facilitation of mossy fiber LTP may be partially due to inhibition of GABA B receptor activation (Jin and Chavkin 1999) . Although the role of I M in LTP processing is still unknown, it seems logical that augmenting I M should prevent the postsynaptic depolarization needed for the expression of many forms of LTP. Interestingly, a novel form of long-term depression (LTD) found in the rat CA1 hippocampus is blocked by naloxone (Francesconi et al. 1997 ), suggesting that endogenous opioids could also play a role in this form of synaptic plasticity. Considering the I M -augmenting (i.e., inhibitory) effect of dynorphin in this region, dynorphin could be implicated in mediating this form of LTD. Dynorphin could also be involved in other phenomena such as paired-pulse inhibition or short-term potentiation. Based on its potent hippocampal actions, it is reasonable to suggest that endogenous dynorphin could play a role in memory function, an idea supported by data showing naloxone-sensitive impairment of spatial memory by dynorphin microinjection into the hippocampus (McDaniel et al. 1990 ). Furthermore, dynorphin B impairs spatial learning in rats via receptors (Sandin et al. 1998) . Additional studies will be required to determine whether the M-current is involved in these seizure-, plasticity-, or memory-related phenomena and whether endogenous dynorphin in hippocampus might have similar effects. As implied in the data of our accompanying paper (Madamba et al. 1999) , similar considerations apply to the possible role of nociceptin in hippocampus.
